Christian Hopfer
Concepts (404)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Substance-Related Disorders | 37 | 2025 | 1083 | 3.660 |
Why?
| | Marijuana Abuse | 21 | 2024 | 233 | 3.510 |
Why?
| | Cannabis | 13 | 2025 | 494 | 3.080 |
Why?
| | Conduct Disorder | 16 | 2023 | 201 | 2.110 |
Why?
| | Marijuana Use | 9 | 2025 | 206 | 1.840 |
Why?
| | Adolescent Behavior | 16 | 2020 | 530 | 1.460 |
Why?
| | Alcoholism | 20 | 2025 | 807 | 1.460 |
Why?
| | Alcohol Drinking | 16 | 2024 | 828 | 1.420 |
Why?
| | Marijuana Smoking | 9 | 2022 | 252 | 1.380 |
Why?
| | Antisocial Personality Disorder | 16 | 2025 | 169 | 1.270 |
Why?
| | Social Environment | 10 | 2014 | 296 | 1.170 |
Why?
| | Tobacco Use Disorder | 11 | 2020 | 251 | 1.130 |
Why?
| | Polymorphism, Single Nucleotide | 22 | 2025 | 2189 | 1.100 |
Why?
| | Adolescent | 93 | 2025 | 21513 | 1.070 |
Why?
| | Siblings | 13 | 2025 | 228 | 1.010 |
Why?
| | Genetic Predisposition to Disease | 17 | 2025 | 2426 | 0.990 |
Why?
| | Twins | 10 | 2025 | 243 | 0.870 |
Why?
| | Genome-Wide Association Study | 15 | 2025 | 1431 | 0.840 |
Why?
| | Smoking | 17 | 2019 | 1627 | 0.810 |
Why?
| | Medical Marijuana | 3 | 2020 | 117 | 0.770 |
Why?
| | Analgesics, Opioid | 7 | 2020 | 1000 | 0.720 |
Why?
| | Risk-Taking | 7 | 2019 | 348 | 0.710 |
Why?
| | Legislation, Drug | 4 | 2023 | 80 | 0.690 |
Why?
| | Mental Disorders | 9 | 2025 | 1077 | 0.670 |
Why?
| | Diagnostic and Statistical Manual of Mental Disorders | 10 | 2018 | 243 | 0.660 |
Why?
| | Young Adult | 38 | 2025 | 13209 | 0.660 |
Why?
| | Female | 97 | 2025 | 73304 | 0.650 |
Why?
| | Humans | 127 | 2025 | 137585 | 0.650 |
Why?
| | Male | 95 | 2025 | 67762 | 0.650 |
Why?
| | Problem Behavior | 2 | 2018 | 102 | 0.640 |
Why?
| | Dronabinol | 2 | 2020 | 226 | 0.640 |
Why?
| | Colorado | 23 | 2022 | 4565 | 0.630 |
Why?
| | Opioid-Related Disorders | 5 | 2021 | 515 | 0.630 |
Why?
| | Cannabinol | 1 | 2019 | 2 | 0.620 |
Why?
| | Diseases in Twins | 4 | 2014 | 169 | 0.610 |
Why?
| | Homeless Youth | 3 | 2008 | 17 | 0.590 |
Why?
| | Hallucinogens | 1 | 2020 | 105 | 0.580 |
Why?
| | Adult | 60 | 2025 | 37929 | 0.580 |
Why?
| | Longitudinal Studies | 26 | 2025 | 2844 | 0.570 |
Why?
| | Criminals | 1 | 2018 | 35 | 0.570 |
Why?
| | Substance Abuse, Intravenous | 3 | 2016 | 115 | 0.560 |
Why?
| | Heroin Dependence | 3 | 2003 | 33 | 0.560 |
Why?
| | Colitis, Ulcerative | 1 | 2019 | 136 | 0.540 |
Why?
| | Prescription Drug Misuse | 1 | 2017 | 41 | 0.540 |
Why?
| | Sexual Behavior | 5 | 2019 | 485 | 0.540 |
Why?
| | Cigarette Smoking | 1 | 2018 | 101 | 0.530 |
Why?
| | Receptors, Nicotinic | 7 | 2016 | 334 | 0.520 |
Why?
| | Genetic Linkage | 3 | 2008 | 297 | 0.510 |
Why?
| | Prescription Drug Diversion | 1 | 2016 | 12 | 0.500 |
Why?
| | Prevalence | 11 | 2022 | 2734 | 0.490 |
Why?
| | Crohn Disease | 1 | 2019 | 243 | 0.470 |
Why?
| | Genotype | 15 | 2019 | 1916 | 0.460 |
Why?
| | Attention Deficit Disorder with Hyperactivity | 6 | 2025 | 413 | 0.460 |
Why?
| | Motivation | 2 | 2018 | 570 | 0.430 |
Why?
| | Accidents, Traffic | 2 | 2018 | 190 | 0.430 |
Why?
| | Inflammatory Bowel Diseases | 1 | 2018 | 351 | 0.410 |
Why?
| | Receptors, Dopamine D2 | 4 | 2007 | 97 | 0.410 |
Why?
| | Body Mass Index | 3 | 2018 | 2389 | 0.410 |
Why?
| | Family Health | 1 | 2014 | 196 | 0.400 |
Why?
| | Polymorphism, Genetic | 4 | 2016 | 660 | 0.380 |
Why?
| | Genetic Variation | 5 | 2022 | 991 | 0.370 |
Why?
| | Comorbidity | 9 | 2016 | 1622 | 0.320 |
Why?
| | Phenotype | 14 | 2020 | 3196 | 0.320 |
Why?
| | Urban Population | 2 | 2012 | 479 | 0.320 |
Why?
| | Surveys and Questionnaires | 13 | 2019 | 5778 | 0.320 |
Why?
| | Substance Abuse Detection | 2 | 2020 | 87 | 0.310 |
Why?
| | Child Abuse | 6 | 2021 | 535 | 0.310 |
Why?
| | Biological Specimen Banks | 4 | 2019 | 102 | 0.310 |
Why?
| | Nurses, Community Health | 2 | 2019 | 33 | 0.310 |
Why?
| | Multifactorial Inheritance | 4 | 2025 | 174 | 0.310 |
Why?
| | Substance Withdrawal Syndrome | 2 | 2019 | 179 | 0.310 |
Why?
| | Prospective Studies | 9 | 2020 | 7604 | 0.310 |
Why?
| | Impulsive Behavior | 4 | 2017 | 150 | 0.300 |
Why?
| | Criminal Behavior | 2 | 2018 | 6 | 0.300 |
Why?
| | Prenatal Care | 3 | 2019 | 294 | 0.300 |
Why?
| | United Kingdom | 3 | 2019 | 318 | 0.300 |
Why?
| | Haplotypes | 5 | 2009 | 494 | 0.290 |
Why?
| | United States | 17 | 2022 | 14841 | 0.290 |
Why?
| | Juvenile Delinquency | 5 | 2018 | 108 | 0.290 |
Why?
| | House Calls | 2 | 2019 | 138 | 0.280 |
Why?
| | Adolescent Development | 2 | 2019 | 86 | 0.280 |
Why?
| | Cognition | 4 | 2020 | 1153 | 0.270 |
Why?
| | Genetic Association Studies | 4 | 2021 | 377 | 0.270 |
Why?
| | Mental Health | 2 | 2025 | 726 | 0.270 |
Why?
| | Cross-Sectional Studies | 9 | 2025 | 5472 | 0.270 |
Why?
| | Sex Factors | 10 | 2017 | 2071 | 0.260 |
Why?
| | Chromosomes, Human, Pair 9 | 1 | 2006 | 41 | 0.260 |
Why?
| | Receptors, Cannabinoid | 1 | 2006 | 15 | 0.260 |
Why?
| | Chromosomes, Human, Pair 3 | 1 | 2006 | 50 | 0.260 |
Why?
| | Health Surveys | 5 | 2012 | 514 | 0.260 |
Why?
| | Case-Control Studies | 10 | 2019 | 3556 | 0.260 |
Why?
| | Multigene Family | 3 | 2013 | 198 | 0.260 |
Why?
| | Drug Prescriptions | 2 | 2018 | 245 | 0.250 |
Why?
| | Analgesics | 2 | 2020 | 206 | 0.250 |
Why?
| | Home Care Services | 2 | 2019 | 257 | 0.250 |
Why?
| | Homosexuality | 1 | 2006 | 17 | 0.250 |
Why?
| | Bisexuality | 1 | 2006 | 31 | 0.250 |
Why?
| | Mothers | 3 | 2019 | 754 | 0.250 |
Why?
| | Receptors, Dopamine D1 | 1 | 2006 | 34 | 0.240 |
Why?
| | Tandem Mass Spectrometry | 2 | 2020 | 532 | 0.240 |
Why?
| | Registries | 1 | 2014 | 2035 | 0.240 |
Why?
| | Tobacco Use | 2 | 2024 | 64 | 0.240 |
Why?
| | Research Subjects | 2 | 2015 | 42 | 0.230 |
Why?
| | Aggression | 4 | 2022 | 202 | 0.230 |
Why?
| | Environment | 5 | 2012 | 358 | 0.230 |
Why?
| | Substance Abuse Treatment Centers | 3 | 2012 | 41 | 0.220 |
Why?
| | Linkage Disequilibrium | 7 | 2021 | 268 | 0.220 |
Why?
| | Genome | 1 | 2006 | 300 | 0.220 |
Why?
| | Child Behavior Disorders | 3 | 2011 | 144 | 0.220 |
Why?
| | Child | 24 | 2025 | 21935 | 0.220 |
Why?
| | Age of Onset | 5 | 2018 | 518 | 0.210 |
Why?
| | Genomics | 3 | 2020 | 795 | 0.210 |
Why?
| | Risk Factors | 13 | 2025 | 10388 | 0.210 |
Why?
| | Internationality | 2 | 2022 | 155 | 0.210 |
Why?
| | Interview, Psychological | 4 | 2013 | 96 | 0.210 |
Why?
| | Twins, Monozygotic | 5 | 2010 | 203 | 0.210 |
Why?
| | Obesity | 1 | 2017 | 2992 | 0.210 |
Why?
| | Alleles | 8 | 2018 | 891 | 0.200 |
Why?
| | Gene Frequency | 6 | 2016 | 521 | 0.200 |
Why?
| | Adoption | 1 | 2003 | 32 | 0.200 |
Why?
| | Genetic Loci | 3 | 2022 | 288 | 0.200 |
Why?
| | Heroin | 1 | 2003 | 31 | 0.200 |
Why?
| | Narcotics | 1 | 2003 | 52 | 0.200 |
Why?
| | Models, Genetic | 6 | 2010 | 600 | 0.200 |
Why?
| | Nerve Tissue Proteins | 5 | 2013 | 596 | 0.190 |
Why?
| | Serotonin Plasma Membrane Transport Proteins | 2 | 2016 | 75 | 0.190 |
Why?
| | Sleep Wake Disorders | 1 | 2025 | 286 | 0.180 |
Why?
| | Incidence | 4 | 2018 | 2804 | 0.180 |
Why?
| | Sleep | 2 | 2025 | 755 | 0.180 |
Why?
| | Age Factors | 6 | 2014 | 3295 | 0.180 |
Why?
| | Attention Deficit and Disruptive Behavior Disorders | 2 | 2013 | 62 | 0.170 |
Why?
| | Public Health | 1 | 2006 | 588 | 0.170 |
Why?
| | Cannabinoid Receptor Agonists | 1 | 2020 | 46 | 0.170 |
Why?
| | Monoamine Oxidase | 2 | 2013 | 30 | 0.160 |
Why?
| | Health Risk Behaviors | 1 | 2019 | 16 | 0.160 |
Why?
| | Nausea | 1 | 2020 | 111 | 0.160 |
Why?
| | Maternal Health | 1 | 2019 | 49 | 0.160 |
Why?
| | Middle Aged | 14 | 2025 | 33479 | 0.160 |
Why?
| | Autistic Disorder | 1 | 2022 | 204 | 0.160 |
Why?
| | Twins, Dizygotic | 4 | 2010 | 175 | 0.160 |
Why?
| | Sleep Initiation and Maintenance Disorders | 1 | 2022 | 165 | 0.160 |
Why?
| | Behavior, Addictive | 1 | 2020 | 81 | 0.150 |
Why?
| | Depression | 3 | 2022 | 1397 | 0.150 |
Why?
| | Pain, Postoperative | 2 | 2019 | 265 | 0.150 |
Why?
| | Minisatellite Repeats | 1 | 2019 | 42 | 0.150 |
Why?
| | Physician Incentive Plans | 1 | 2018 | 7 | 0.150 |
Why?
| | Expressed Emotion | 1 | 2018 | 17 | 0.150 |
Why?
| | Calcium-Transporting ATPases | 1 | 2018 | 40 | 0.150 |
Why?
| | Mortality, Premature | 1 | 2018 | 14 | 0.150 |
Why?
| | HIV Infections | 1 | 2013 | 2836 | 0.150 |
Why?
| | Multimodal Imaging | 1 | 2019 | 113 | 0.150 |
Why?
| | Chromatography, Liquid | 1 | 2020 | 433 | 0.140 |
Why?
| | Digestive System Surgical Procedures | 1 | 2019 | 106 | 0.140 |
Why?
| | Analgesics, Non-Narcotic | 1 | 2019 | 125 | 0.140 |
Why?
| | Pregnancy | 5 | 2022 | 6763 | 0.140 |
Why?
| | Feeding and Eating Disorders | 1 | 2020 | 152 | 0.140 |
Why?
| | Urine | 1 | 2017 | 59 | 0.140 |
Why?
| | Cannabinoids | 2 | 2017 | 161 | 0.140 |
Why?
| | Bioethics | 1 | 2017 | 19 | 0.130 |
Why?
| | Receptors, Opioid, mu | 2 | 2015 | 74 | 0.130 |
Why?
| | Unsafe Sex | 2 | 2016 | 60 | 0.130 |
Why?
| | Biomedical Research | 2 | 2014 | 692 | 0.130 |
Why?
| | Physicians, Family | 1 | 2018 | 201 | 0.130 |
Why?
| | Neuropsychological Tests | 2 | 2020 | 1023 | 0.130 |
Why?
| | Infant, Newborn | 4 | 2020 | 6079 | 0.130 |
Why?
| | Administration, Oral | 1 | 2019 | 816 | 0.130 |
Why?
| | Counseling | 1 | 2020 | 391 | 0.130 |
Why?
| | Gene-Environment Interaction | 2 | 2020 | 192 | 0.130 |
Why?
| | Brain | 2 | 2019 | 2668 | 0.130 |
Why?
| | Suicide | 2 | 2021 | 656 | 0.130 |
Why?
| | Brain Mapping | 1 | 2019 | 503 | 0.130 |
Why?
| | Receptors, Metabotropic Glutamate | 1 | 2016 | 40 | 0.130 |
Why?
| | Depressive Disorder, Major | 2 | 2020 | 364 | 0.120 |
Why?
| | Mental Competency | 1 | 2015 | 25 | 0.120 |
Why?
| | Plasma | 1 | 2017 | 212 | 0.120 |
Why?
| | Drug Storage | 1 | 2016 | 57 | 0.120 |
Why?
| | Patient Admission | 2 | 2012 | 197 | 0.120 |
Why?
| | Lipids | 1 | 2020 | 672 | 0.120 |
Why?
| | Self Report | 2 | 2018 | 827 | 0.120 |
Why?
| | Surgical Procedures, Operative | 1 | 2018 | 259 | 0.120 |
Why?
| | Drug Overdose | 2 | 2018 | 347 | 0.120 |
Why?
| | Neuroimaging | 1 | 2017 | 259 | 0.120 |
Why?
| | Image Processing, Computer-Assisted | 1 | 2019 | 752 | 0.110 |
Why?
| | Exploratory Behavior | 2 | 2013 | 92 | 0.110 |
Why?
| | Life Change Events | 1 | 2016 | 151 | 0.110 |
Why?
| | Interviews as Topic | 3 | 2007 | 786 | 0.110 |
Why?
| | Informed Consent | 1 | 2015 | 175 | 0.110 |
Why?
| | Automobile Driving | 1 | 2016 | 148 | 0.110 |
Why?
| | Patient Satisfaction | 1 | 2018 | 660 | 0.110 |
Why?
| | Pregnancy Complications | 1 | 2019 | 527 | 0.110 |
Why?
| | Medicine | 1 | 2016 | 121 | 0.110 |
Why?
| | Aged | 6 | 2018 | 23961 | 0.110 |
Why?
| | Netherlands | 1 | 2014 | 88 | 0.110 |
Why?
| | Practice Patterns, Physicians' | 3 | 2019 | 1313 | 0.110 |
Why?
| | Cohort Studies | 6 | 2021 | 5742 | 0.110 |
Why?
| | Regression Analysis | 3 | 2019 | 1024 | 0.110 |
Why?
| | Time Factors | 3 | 2019 | 6828 | 0.100 |
Why?
| | Genetic Testing | 1 | 2016 | 460 | 0.100 |
Why?
| | Proteomics | 1 | 2020 | 1111 | 0.100 |
Why?
| | Temperament | 1 | 2013 | 46 | 0.100 |
Why?
| | Condoms | 1 | 2013 | 103 | 0.100 |
Why?
| | Conflict of Interest | 1 | 2014 | 130 | 0.100 |
Why?
| | Receptors, GABA-A | 1 | 2014 | 142 | 0.100 |
Why?
| | Emotions | 2 | 2021 | 548 | 0.100 |
Why?
| | Patient Safety | 1 | 2016 | 314 | 0.100 |
Why?
| | Severity of Illness Index | 2 | 2019 | 2828 | 0.090 |
Why?
| | Receptors, Oxytocin | 1 | 2012 | 23 | 0.090 |
Why?
| | Family Conflict | 1 | 2012 | 41 | 0.090 |
Why?
| | Sexual Partners | 1 | 2013 | 186 | 0.090 |
Why?
| | Socioeconomic Factors | 2 | 2013 | 1289 | 0.090 |
Why?
| | Multivariate Analysis | 2 | 2012 | 1509 | 0.090 |
Why?
| | Family Relations | 1 | 2012 | 91 | 0.090 |
Why?
| | Educational Status | 1 | 2013 | 470 | 0.090 |
Why?
| | Pentachlorophenol | 1 | 1990 | 21 | 0.080 |
Why?
| | Ethanol | 2 | 2012 | 608 | 0.080 |
Why?
| | Logistic Models | 4 | 2019 | 2074 | 0.080 |
Why?
| | Dizziness | 1 | 2010 | 82 | 0.080 |
Why?
| | Psychometrics | 3 | 2009 | 720 | 0.080 |
Why?
| | Models, Theoretical | 1 | 2013 | 578 | 0.080 |
Why?
| | Sample Size | 2 | 2022 | 125 | 0.080 |
Why?
| | Models, Statistical | 2 | 2010 | 669 | 0.080 |
Why?
| | Genetic Markers | 2 | 2007 | 344 | 0.080 |
Why?
| | Hospitalization | 1 | 2019 | 2199 | 0.080 |
Why?
| | Receptor, Cannabinoid, CB1 | 1 | 2009 | 45 | 0.080 |
Why?
| | Biomarkers | 1 | 2020 | 4149 | 0.070 |
Why?
| | Taq Polymerase | 2 | 2006 | 10 | 0.070 |
Why?
| | Magnetic Resonance Imaging | 2 | 2019 | 3566 | 0.070 |
Why?
| | Child Abuse, Sexual | 1 | 2009 | 88 | 0.070 |
Why?
| | Suicidal Ideation | 3 | 2021 | 529 | 0.070 |
Why?
| | Primary Health Care | 1 | 2018 | 1738 | 0.070 |
Why?
| | Disruptive, Impulse Control, and Conduct Disorders | 1 | 2007 | 11 | 0.070 |
Why?
| | Methylphenidate | 2 | 2004 | 38 | 0.070 |
Why?
| | Retrospective Studies | 8 | 2021 | 15657 | 0.070 |
Why?
| | Stress, Psychological | 1 | 2016 | 1100 | 0.070 |
Why?
| | Emergency Service, Hospital | 1 | 2019 | 2069 | 0.070 |
Why?
| | Deoxyribonucleases, Type II Site-Specific | 1 | 2007 | 15 | 0.070 |
Why?
| | Polymorphism, Restriction Fragment Length | 1 | 2007 | 68 | 0.070 |
Why?
| | Statistics as Topic | 1 | 2008 | 307 | 0.070 |
Why?
| | Risk | 2 | 2020 | 912 | 0.070 |
Why?
| | Quality of Life | 1 | 2019 | 2892 | 0.070 |
Why?
| | Family | 4 | 2016 | 671 | 0.070 |
Why?
| | Schizophrenia | 2 | 2022 | 439 | 0.060 |
Why?
| | 3' Untranslated Regions | 1 | 2007 | 145 | 0.060 |
Why?
| | Child of Impaired Parents | 1 | 2006 | 41 | 0.060 |
Why?
| | Cheek | 1 | 2006 | 17 | 0.060 |
Why?
| | Fathers | 1 | 2006 | 50 | 0.060 |
Why?
| | Lysergic Acid Diethylamide | 1 | 2006 | 2 | 0.060 |
Why?
| | Social Facilitation | 1 | 2006 | 9 | 0.060 |
Why?
| | Sodium Oxybate | 1 | 2006 | 4 | 0.060 |
Why?
| | N-Methyl-3,4-methylenedioxyamphetamine | 1 | 2006 | 12 | 0.060 |
Why?
| | Microsatellite Repeats | 1 | 2006 | 168 | 0.060 |
Why?
| | Central Nervous System Stimulants | 2 | 2004 | 161 | 0.060 |
Why?
| | Alcohol-Related Disorders | 1 | 2007 | 122 | 0.060 |
Why?
| | Protein Kinase C | 1 | 2007 | 261 | 0.060 |
Why?
| | Genetics, Population | 1 | 2007 | 214 | 0.060 |
Why?
| | Poverty | 2 | 2019 | 521 | 0.060 |
Why?
| | Religion | 1 | 2006 | 71 | 0.060 |
Why?
| | Parenting | 1 | 2009 | 310 | 0.060 |
Why?
| | Parents | 2 | 2004 | 1347 | 0.060 |
Why?
| | Confidence Intervals | 2 | 2006 | 329 | 0.060 |
Why?
| | Methamphetamine | 1 | 2006 | 63 | 0.060 |
Why?
| | Ketamine | 1 | 2006 | 94 | 0.060 |
Why?
| | Beta Rhythm | 1 | 2004 | 21 | 0.060 |
Why?
| | Suicide, Attempted | 1 | 2008 | 378 | 0.060 |
Why?
| | Universities | 1 | 2007 | 433 | 0.060 |
Why?
| | Pain Management | 2 | 2019 | 352 | 0.050 |
Why?
| | Marriage | 1 | 2004 | 121 | 0.050 |
Why?
| | Data Interpretation, Statistical | 3 | 2010 | 363 | 0.050 |
Why?
| | Treatment Outcome | 3 | 2019 | 10811 | 0.050 |
Why?
| | Drug Tolerance | 1 | 2003 | 105 | 0.050 |
Why?
| | Genome, Human | 2 | 2020 | 425 | 0.050 |
Why?
| | Membrane Transport Proteins | 1 | 2003 | 162 | 0.050 |
Why?
| | Infant | 3 | 2021 | 9465 | 0.050 |
Why?
| | Europe | 1 | 2022 | 414 | 0.050 |
Why?
| | Loneliness | 1 | 2022 | 45 | 0.050 |
Why?
| | Models, Psychological | 2 | 2016 | 301 | 0.050 |
Why?
| | Sensitivity and Specificity | 2 | 2021 | 1946 | 0.050 |
Why?
| | Predictive Value of Tests | 2 | 2021 | 2031 | 0.040 |
Why?
| | Methadone | 1 | 2002 | 101 | 0.040 |
Why?
| | Personality Assessment | 2 | 2013 | 84 | 0.040 |
Why?
| | Calibration | 1 | 2021 | 146 | 0.040 |
Why?
| | Electroencephalography | 1 | 2003 | 423 | 0.040 |
Why?
| | Proportional Hazards Models | 2 | 2018 | 1266 | 0.040 |
Why?
| | Membrane Glycoproteins | 1 | 2003 | 500 | 0.040 |
Why?
| | Follow-Up Studies | 2 | 2019 | 5131 | 0.040 |
Why?
| | Polymerase Chain Reaction | 2 | 2014 | 1062 | 0.040 |
Why?
| | Bayes Theorem | 1 | 2021 | 405 | 0.040 |
Why?
| | Minnesota | 1 | 2020 | 164 | 0.040 |
Why?
| | Bipolar Disorder | 1 | 2022 | 263 | 0.040 |
Why?
| | Drug Utilization Review | 1 | 2019 | 57 | 0.040 |
Why?
| | Interrupted Time Series Analysis | 1 | 2019 | 68 | 0.040 |
Why?
| | Dangerous Behavior | 1 | 2018 | 19 | 0.040 |
Why?
| | Infant, Small for Gestational Age | 1 | 2019 | 92 | 0.040 |
Why?
| | Signal Processing, Computer-Assisted | 1 | 2019 | 145 | 0.040 |
Why?
| | Electronic Mail | 1 | 2018 | 64 | 0.040 |
Why?
| | Diffusion Magnetic Resonance Imaging | 1 | 2019 | 153 | 0.040 |
Why?
| | Atmospheric Pressure | 1 | 2017 | 23 | 0.040 |
Why?
| | Statistics, Nonparametric | 2 | 2012 | 431 | 0.030 |
Why?
| | Factor Analysis, Statistical | 2 | 2010 | 283 | 0.030 |
Why?
| | Preoperative Period | 1 | 2018 | 129 | 0.030 |
Why?
| | Safety-net Providers | 1 | 2019 | 119 | 0.030 |
Why?
| | Limit of Detection | 1 | 2017 | 85 | 0.030 |
Why?
| | Tobacco Products | 1 | 2019 | 138 | 0.030 |
Why?
| | Epidemics | 1 | 2018 | 89 | 0.030 |
Why?
| | Gene Expression | 2 | 2016 | 1502 | 0.030 |
Why?
| | Postoperative Period | 1 | 2018 | 342 | 0.030 |
Why?
| | Pregnancy Outcome | 1 | 2019 | 416 | 0.030 |
Why?
| | Child, Preschool | 2 | 2022 | 11074 | 0.030 |
Why?
| | Executive Function | 1 | 2021 | 451 | 0.030 |
Why?
| | Psychiatric Status Rating Scales | 2 | 2010 | 547 | 0.030 |
Why?
| | Chromosome Mapping | 2 | 2008 | 523 | 0.030 |
Why?
| | Transcriptome | 1 | 2022 | 971 | 0.030 |
Why?
| | CD56 Antigen | 1 | 2016 | 35 | 0.030 |
Why?
| | California | 1 | 2017 | 431 | 0.030 |
Why?
| | Cause of Death | 1 | 2018 | 434 | 0.030 |
Why?
| | Nicotine | 2 | 2010 | 334 | 0.030 |
Why?
| | Mortality | 1 | 2018 | 362 | 0.030 |
Why?
| | Quality Control | 1 | 2016 | 172 | 0.030 |
Why?
| | Violence | 1 | 2018 | 266 | 0.030 |
Why?
| | Chromatography, High Pressure Liquid | 1 | 2017 | 597 | 0.030 |
Why?
| | Potassium Channels | 1 | 2016 | 151 | 0.030 |
Why?
| | Psychology, Adolescent | 1 | 2015 | 66 | 0.030 |
Why?
| | Heterozygote | 1 | 2016 | 293 | 0.030 |
Why?
| | Reward | 1 | 2017 | 244 | 0.030 |
Why?
| | Thoracic Surgical Procedures | 1 | 2016 | 73 | 0.030 |
Why?
| | Practice Guidelines as Topic | 1 | 2003 | 1587 | 0.030 |
Why?
| | Cell Adhesion Molecules | 1 | 2016 | 181 | 0.030 |
Why?
| | Anxiety | 1 | 2022 | 1035 | 0.030 |
Why?
| | Likelihood Functions | 1 | 2015 | 144 | 0.030 |
Why?
| | Sexually Transmitted Diseases | 1 | 2016 | 161 | 0.030 |
Why?
| | Demography | 1 | 2015 | 291 | 0.030 |
Why?
| | Cesarean Section | 1 | 2016 | 184 | 0.030 |
Why?
| | Aging | 1 | 2004 | 1864 | 0.030 |
Why?
| | Disclosure | 1 | 2014 | 113 | 0.030 |
Why?
| | Arsenites | 1 | 1993 | 6 | 0.030 |
Why?
| | Arsenic Poisoning | 1 | 1993 | 7 | 0.030 |
Why?
| | Cotinine | 1 | 2013 | 77 | 0.030 |
Why?
| | Arsenicals | 1 | 1993 | 30 | 0.030 |
Why?
| | Gluconeogenesis | 1 | 1993 | 79 | 0.030 |
Why?
| | Risk Assessment | 2 | 2015 | 3457 | 0.030 |
Why?
| | Chelating Agents | 1 | 1993 | 75 | 0.030 |
Why?
| | Academic Medical Centers | 1 | 2016 | 512 | 0.020 |
Why?
| | Kidney Tubules | 1 | 1993 | 117 | 0.020 |
Why?
| | Child Behavior | 2 | 2005 | 248 | 0.020 |
Why?
| | Psychological Theory | 1 | 2013 | 97 | 0.020 |
Why?
| | Probability | 1 | 2013 | 304 | 0.020 |
Why?
| | Databases, Factual | 1 | 2018 | 1357 | 0.020 |
Why?
| | Privacy | 1 | 2012 | 42 | 0.020 |
Why?
| | Students | 1 | 2017 | 622 | 0.020 |
Why?
| | Carrier Proteins | 1 | 2016 | 771 | 0.020 |
Why?
| | Pedigree | 1 | 2013 | 514 | 0.020 |
Why?
| | Antidotes | 1 | 1993 | 143 | 0.020 |
Why?
| | Disease Progression | 1 | 2018 | 2757 | 0.020 |
Why?
| | Software | 1 | 2016 | 665 | 0.020 |
Why?
| | Pleasure | 1 | 2010 | 19 | 0.020 |
Why?
| | Reproducibility of Results | 2 | 2009 | 3284 | 0.020 |
Why?
| | Attitude of Health Personnel | 1 | 2018 | 1171 | 0.020 |
Why?
| | Sensation | 1 | 2010 | 53 | 0.020 |
Why?
| | Chromatography, Gas | 1 | 1990 | 33 | 0.020 |
Why?
| | Rats, Inbred Strains | 1 | 1990 | 362 | 0.020 |
Why?
| | Prognosis | 1 | 2018 | 4030 | 0.020 |
Why?
| | Exercise | 1 | 2021 | 2057 | 0.020 |
Why?
| | Negotiating | 1 | 2009 | 32 | 0.020 |
Why?
| | Membrane Proteins | 1 | 2016 | 1164 | 0.020 |
Why?
| | Cooperative Behavior | 1 | 2012 | 451 | 0.020 |
Why?
| | Patient Discharge | 1 | 2016 | 897 | 0.020 |
Why?
| | Psychological Tests | 1 | 2010 | 140 | 0.020 |
Why?
| | Molecular Structure | 1 | 1990 | 489 | 0.020 |
Why?
| | Epistasis, Genetic | 1 | 2009 | 70 | 0.020 |
Why?
| | Personality Inventory | 1 | 2009 | 139 | 0.020 |
Why?
| | Mouth Mucosa | 1 | 2007 | 92 | 0.020 |
Why?
| | Reverse Transcriptase Polymerase Chain Reaction | 1 | 2009 | 976 | 0.020 |
Why?
| | Odds Ratio | 1 | 2009 | 1070 | 0.020 |
Why?
| | Analysis of Variance | 1 | 2009 | 1316 | 0.020 |
Why?
| | Parent-Child Relations | 1 | 2009 | 272 | 0.020 |
Why?
| | Oligonucleotide Array Sequence Analysis | 1 | 2008 | 767 | 0.020 |
Why?
| | Rats | 2 | 1993 | 5647 | 0.010 |
Why?
| | Linear Models | 1 | 2007 | 849 | 0.010 |
Why?
| | Reference Values | 1 | 2006 | 816 | 0.010 |
Why?
| | Aged, 80 and over | 1 | 2016 | 7635 | 0.010 |
Why?
| | Frontal Lobe | 1 | 2004 | 149 | 0.010 |
Why?
| | Chi-Square Distribution | 1 | 2004 | 530 | 0.010 |
Why?
| | Dopamine Plasma Membrane Transport Proteins | 1 | 2003 | 57 | 0.010 |
Why?
| | Schools | 1 | 2006 | 461 | 0.010 |
Why?
| | Research Design | 1 | 2009 | 1139 | 0.010 |
Why?
| | Housing | 1 | 2004 | 146 | 0.010 |
Why?
| | Family Characteristics | 1 | 2004 | 191 | 0.010 |
Why?
| | Attention | 1 | 2004 | 427 | 0.010 |
Why?
| | Transcription, Genetic | 1 | 2007 | 1457 | 0.010 |
Why?
| | Algorithms | 1 | 2008 | 1704 | 0.010 |
Why?
| | DNA | 1 | 2007 | 1459 | 0.010 |
Why?
| | Cognition Disorders | 1 | 2003 | 496 | 0.010 |
Why?
| | Double-Blind Method | 1 | 2003 | 1993 | 0.010 |
Why?
| | Arsenates | 1 | 1993 | 1 | 0.010 |
Why?
| | Unithiol | 1 | 1993 | 2 | 0.010 |
Why?
| | Dimercaprol | 1 | 1993 | 6 | 0.010 |
Why?
| | Succimer | 1 | 1993 | 4 | 0.010 |
Why?
| | Drug Evaluation, Preclinical | 1 | 1993 | 184 | 0.010 |
Why?
| | Mice, Inbred Strains | 1 | 1993 | 409 | 0.010 |
Why?
| | Arsenic | 1 | 1993 | 64 | 0.010 |
Why?
| | Animals | 2 | 1993 | 36940 | 0.010 |
Why?
| | In Vitro Techniques | 1 | 1993 | 1092 | 0.010 |
Why?
| | Rats, Sprague-Dawley | 1 | 1993 | 2486 | 0.000 |
Why?
| | Mice | 1 | 1993 | 17787 | 0.000 |
Why?
|
|
Hopfer's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors  People in Profiles who have published with this person. _
Similar People  People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors  People whose addresses are nearby this person. _
|